Goals of ICSC’s Spoke arela progettazione di nuovi test clinici eseguiti con metodi simulativi, al fine di ridurre tempi e costi dei trial clinici, e lo sviluppo di una piattaforma tecnologica che consenta l’analisi di big data mediante algoritmi di intelligenza artificiale e machine learning. Questi studi permetteranno di aumentare la comprensione di numerose patologie, la loro diagnosi e prognosi, nonché di sviluppare nuovi trattamenti farmacologici personalizzati.
Number of Grants: 1
Thematic Areas Funded:
1- Hardening of cloud systems for deployment of in silico medicine solutions on GDPR compliance platforms.
2- Development and testing of in silico trials and/or digital twins solutions for neurodegenerative diseases with autoimmune component (RESTRICTED TO SOUTHERN ITALY ENTITIES).
3- Development and testing of pathway analysis and drug repositioning solutions.
4- Increasing the number of tumor and non-tumor tissue samples (and/or blood samples) from operable (and non-operable) patients diagnosed with PDAC and/or other oncological diseases.
5- Production and analysis of multi-omics (non-genomic) data including proteomics, metabolomics, lipidomics, etc., and imaging on tissue (and/or plasma) samples from patients diagnosed with PDAC and/or other oncological diseases. Advanced Integration of Omics and Imaging Data through Artificial Intelligence-based Methods for the identification and validation of novel drug targets.
6- Production and analysis of metagenomics data from PDAC patients. The project should include sample collection, microbiota genome extraction and bioinformatics analysis.
Deadline: 26/03/2024, 12:00
Budget: 3.200.000 Euro
Grant
Proponent: Italian Institute of Technology (IIT)
Description:
Who it is addressed to:
Micro, Small and Medium Enterprises (MSMEs), outside the NC and competing in single mode, having the size parameters set out in Annex I of Commission REG (EC) No. 800/2008 of August 6, 2008 (General Block Exemption Regulation) in OJEU L 214, 9.8.2008.
Large Enterprises (GIs), outside the CN.
the Italian State Universities, outside the CN.
Italian non-State Universities legally recognized and accredited MUR, outside the CN.
Research Organizations (RFOs) within the meaning of Regulation (EU) 651/2014, item 83, external to the CN.
Public and private consortia established among the above beneficiaries. Consortia may also be established, through ATI/ATS, or other form recognized by the Italian State, following the awarding of projects.
Budget: 3.200.000 Euro
Deadline: 26/03/2024, 12:00
This site uses technical cookies, which are necessary for its proper functioning and to manage authentication to online services and restricted areas. The use of these cookies is strictly limited to the transmission of session identifiers. Their deactivation could affect the use of part of the online services. By using our site you consent to the placement of this type of cookie on your device.
This website uses cookies to improve your experience while browsing the website. Of these, cookies that are categorized as necessary are stored in your browser as they are essential for the basic functionality of the website to work. We also use third party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to disable these cookies. However, disabling some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies guarantee the basic functionality and security features of the website, anonymously.
Functional cookies are strictly necessary to provide the services of the shop, as well as for its proper functioning, so it is not possible to refuse their use. They allow the user to browse through our website and use the different options or services that exist on it.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on visitor numbers, bounce rate, traffic source, etc.